Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

Clinical protocol for phase I/II testing of tgAAV-CFTR

June 5, 1998

Zyrtec approved for use in children as young as two years

June 5, 1998

Neurokinin antagonists in the pipeline at Schering-Plough

June 4, 1998

Byk Gulden's new PDE IV inhibitors

June 4, 1998

AxyS files IND for dry powder inhalation formulation of APC-366

June 4, 1998

Nikken Chemicals presents new antiasthmatic agents

June 3, 1998

New lipoxygenase inhibitors for asthma and other inflammatory conditions

June 2, 1998

New tachykinin antagonists patented by Pfizer

May 29, 1998

Neurokinin antagonists for bronchoconstriction, neurogenic inflammation

May 29, 1998

Multiple-dose pharmacokinetics/pharmacodynamics reported for ABT-761

May 28, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
ADEL wins $1.04B Sanofi deal for tau-targeting Alzheimer’s drug
BioWorld
ADEL Inc. closed a year-end licensing deal worth up to $1.04 billion with Sanofi SA for ADEL-Y01, a specific tau-targeting Alzheimer’s disease drug candidate in a...